Patent ID: 6664369
Filing Date: 2003-12-16
Classification: C07K

Abstract:
A compound selected from the group consisting of:[Lys(&egr;-Fmoc)]5-gonadotropin-releasing hormone (GnRH-III, Lys5-GnRH-III, Lys5,cyclo[Asp6-Lys8]-GnRH-III, Lys5,[Lys(&egr;-Fmoc)]8-GnRH-III, Lys4,[Lys(&egr;-Fmoc)]8-GnRH-III, Lys4-GnRH-III, [Lys(&egr;-Ac)]4-GnRH-III, Glu6-GnRH-III, cyclo[ASP6-Lys8]-GnRH-III, D-Ala10-GnRH)-III, H-D-Trp1,[Lys(&egr;-Fmoc)]8, D-Ala10-GnRH-III, Ac-D-Trp1, D-Ala10-GnRH-III, H-D-Trp1, D-Ala10-GnRH-III, [Trp(For-Ind)]3,7-GnRH-III, Phe7-GnRH-III, GnRH-III(1-9)-ethylamide, Lys5, D-Trp6-human gonadotropin-releasing hormone (hGnRH), Lys4, D-Trp6-hGnRH, H-Glu1, D-Trp6-hGnRH, Lys5, D-Phe6-hGnRH(1-9)-ethylamide, Lys4, D-Phe6-hGnRH(1-9)-ethylamide, Lys5, D-Cpa6-hGnRH(1-9)-ethylanuide; as well as pharmaceutically acceptable salts and esters of these compounds.